Literature DB >> 19576882

Melatonin protects against alcoholic liver injury by attenuating oxidative stress, inflammatory response, and apoptosis.

Shilian Hu1, Shi Yin, Xiaodong Jiang, Dabing Huang, Gan Shen.   

Abstract

Melatonin is reported to exhibit a wide variety of biological effects, including antioxidant and anti-inflammatory. Previous studies show that melatonin has a protective role in different types of liver injury and fibrosis. But its role in the pathogenesis of alcoholic liver injury remains obscure. The present investigation was designed to determine the effects of melatonin on alcohol-induced hepatic injury in mice. The degree of alcoholic liver injury was evaluated by measuring serum markers and pathological examination. Treatment with melatonin significantly attenuated the increased level of serum aminotransferase, reduced the severe extent of hepatic cell damage, steatosis and the immigration of inflammatory cells, but had no effects on hepatic expression of lipogenic genes. Furthermore, melatonin decreased serum and tissue inflammatory cytokines levels, tissue lipid peroxidation, neutrophil infiltration and inhibited the apoptosis of hepatocytes. Kupffer cells isolated from ethanol-fed mice produced high amounts of reactive oxygen species and tumor necrosis factor alpha, whereas Kupffer cells from melatonin treatment mice produced less reactive oxygen species and tumor necrosis factor alpha compared with model alcohol-feeding mice. These findings suggest that melatonin may represent a novel, protective strategy against alcoholic liver injury by attenuating oxidative stress, inflammatory response and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19576882     DOI: 10.1016/j.ejphar.2009.06.044

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  20 in total

Review 1.  Hepatoprotective actions of melatonin: possible mediation by melatonin receptors.

Authors:  Alexander M Mathes
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

2.  Melatonin inhibits cholangiocyte hyperplasia in cholestatic rats by interaction with MT1 but not MT2 melatonin receptors.

Authors:  Anastasia Renzi; Shannon Glaser; Sharon Demorrow; Romina Mancinelli; Fanyin Meng; Antonio Franchitto; Julie Venter; Mellanie White; Heather Francis; Yuyan Han; Domenico Alvaro; Eugenio Gaudio; Guido Carpino; Yoshiyuki Ueno; Paolo Onori; Gianfranco Alpini
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-07-14       Impact factor: 4.052

3.  Pinealectomy or light exposure exacerbates biliary damage and liver fibrosis in cholestatic rats through decreased melatonin synthesis.

Authors:  Lixian Chen; Tianhao Zhou; Nan Wu; April O'Brien; Julie Venter; Ludovica Ceci; Konstantina Kyritsi; Paolo Onori; Eugenio Gaudio; Amelia Sybenga; Linglin Xie; Chaodong Wu; Luca Fabris; Pietro Invernizzi; David Zawieja; Suthat Liangpunsakul; Fanyin Meng; Heather Francis; Gianfranco Alpini; Qiaobing Huang; Shannon Glaser
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-03-16       Impact factor: 5.187

4.  Melatonin Ameliorates Liver Fibrosis Induced by Carbon Tetrachloride in Rats via Inhibiting TGF-β1/Smad Signaling Pathway.

Authors:  Yu-Rong Wang; Ru-Tao Hong; Yuan-Yuan Xie; Jian-Ming Xu
Journal:  Curr Med Sci       Date:  2018-04-30

5.  Prolonged exposure of cholestatic rats to complete dark inhibits biliary hyperplasia and liver fibrosis.

Authors:  Yuyan Han; Paolo Onori; Fanyin Meng; Sharon DeMorrow; Julie Venter; Heather Francis; Antonio Franchitto; Debolina Ray; Lindsey Kennedy; John Greene; Anastasia Renzi; Romina Mancinelli; Eugenio Gaudio; Shannon Glaser; Gianfranco Alpini
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-09-11       Impact factor: 4.052

Review 6.  Oxidative stress as a crucial factor in liver diseases.

Authors:  Halina Cichoż-Lach; Agata Michalak
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

Review 7.  Melatonin role preventing steatohepatitis and improving liver transplantation results.

Authors:  Eduardo Esteban-Zubero; Francisco Agustín García-Gil; Laura López-Pingarrón; Moisés Alejandro Alatorre-Jiménez; José Manuel Ramírez; Dun-Xian Tan; José Joaquín García; Russel J Reiter
Journal:  Cell Mol Life Sci       Date:  2016-03-29       Impact factor: 9.261

Review 8.  Possible application of melatonin treatment in human diseases of the biliary tract.

Authors:  Leonardo Baiocchi; Tianhao Zhou; Suthat Liangpunsakul; Lenci Ilaria; Martina Milana; Fanyin Meng; Lindsey Kennedy; Praveen Kusumanchi; Zhihong Yang; Ludovica Ceci; Shannon Glaser; Heather Francis; Gianfranco Alpini
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2019-09-11       Impact factor: 4.052

Review 9.  Melatonin regulation of biliary functions.

Authors:  Shannon Glaser; Yuyan Han; Heather Francis; Gianfranco Alpini
Journal:  Hepatobiliary Surg Nutr       Date:  2014-02       Impact factor: 7.293

Review 10.  Melatonin and circadian rhythms in liver diseases: Functional roles and potential therapies.

Authors:  Keisaku Sato; Fanyin Meng; Heather Francis; Nan Wu; Lixian Chen; Lindsey Kennedy; Tianhao Zhou; Antonio Franchitto; Paolo Onori; Eugenio Gaudio; Shannon Glaser; Gianfranco Alpini
Journal:  J Pineal Res       Date:  2020-03-04       Impact factor: 13.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.